USPTO serial 75772985
ALARA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCMORROW, JANICE LEE
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ALARA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Peter S. Sloane
PETER S. SLOANE OSTROLENK, FABER, GERB & SOFFEN, LLP1180 AVENUE OF THE AMERICASNEW YORK, NY 10036-8403UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Promoting the pharmaceutical products of others, namely, analgesics, decongestants, and pharmaceutical preparations for the treatment of diabetes, cardiovascular disease, depression, thyroid dysfunction, arthritis, osteoporosis, infection, and anxiety disorders, through the distribution of printed and audio promotional materials, all excluding transdermal estrogen replacement patches; wholesale distributorship services featuring pharmaceuticals, namely, analgesics, decongestants, and pharmaceutical preparations for the treatment of diabetes, cardiovascular disease, depression, thyroid dysfunction, arthritis, osteoporosis, infection, and anxiety disorders, all excluding transdermal estrogen replacement patches | ABANDONED | — |
| 040 | Custom manufacture of pharmaceutical products, namely, analgesics, decongestants, and pharmaceutical preparations for the treatment of diabetes, cardiovascular disease, depression, thyroid dysfunction, arthritis, osteoporosis, infection, and anxiety disorders, all excluding transdermal estrogen replacement patches | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 28, 2007 | MAB4 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | — |
| Nov 28, 2007 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Nov 28, 2007 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| May 2, 2007 | PAPER RECEIVED | — | |
| Sep 19, 2006 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Sep 19, 2006 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Feb 14, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2005 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Oct 5, 2005 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Feb 25, 2005 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Feb 10, 2005 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jan 5, 2005 | PAPER RECEIVED | — | |
| Nov 23, 2004 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Nov 23, 2004 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Aug 19, 2004 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jun 18, 2004 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Apr 26, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 25, 2003 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Apr 10, 2003 | PAPER RECEIVED | — | |
| Dec 4, 2002 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 22, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 19, 2002 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Aug 6, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 26, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 25, 2002 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 1, 2002 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| May 17, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2002 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jan 31, 2002 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Oct 11, 2001 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 21, 2001 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jul 18, 2001 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jan 22, 2001 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 24, 2000 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 24, 1999 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 1999 | DOCK | ASSIGNED TO EXAMINER | — |